Immediate Impact
2 by Nobel laureates 6 from Science/Nature 60 standout
Citing Papers
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Oxytocin pathway gene networks in the human brain
2019 Standout
Works of Steven Paul being referenced
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer disease.
1997
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Steven Paul | 186 | 88 | 68 | 140 | 5 | 413 | |
| Virginia C. Lazarowitz | 285 | 20 | 60 | 62 | 9 | 509 | |
| Alexandra M. Hopwood | 102 | 16 | 130 | 83 | 13 | 436 | |
| K. M. McDonald | 109 | 34 | 95 | 64 | 14 | 509 | |
| Markus Daschner | 117 | 43 | 172 | 163 | 12 | 456 | |
| A. Medina | 110 | 38 | 54 | 49 | 7 | 394 | |
| Robert J. M. Strack van Schijndel | 106 | 75 | 31 | 39 | 10 | 497 | |
| J. C. Eaton | 118 | 46 | 39 | 62 | 7 | 375 | |
| Joseph A. Martino | 174 | 50 | 111 | 78 | 11 | 411 | |
| G. Heberer | 25 | 27 | 47 | 97 | 2 | 416 | |
| Yanauri Bravo | 125 | 130 | 49 | 50 | 11 | 502 |
All Works
Loading papers...